RECURRENT ADRENOCORTICAL CARCINOMA (ACC)

Clinical trials for RECURRENT ADRENOCORTICAL CARCINOMA (ACC) explained in plain language.

Never miss a new study

Get alerted when new RECURRENT ADRENOCORTICAL CARCINOMA (ACC) trials appear

Sign up with your email to follow new studies for RECURRENT ADRENOCORTICAL CARCINOMA (ACC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for rare cancer: radiation before surgery trial seeks to stop recurrence

Disease control Recruiting now

This study is testing if giving targeted radiation therapy before surgery is safe and can help control a rare and aggressive adrenal gland cancer that has come back after initial treatment. It will enroll up to 32 adults whose recurrent cancer can still be surgically removed. The…

Matched conditions: RECURRENT ADRENOCORTICAL CARCINOMA (ACC)

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

RECURRENT ADRENOCORTICAL CARCINOMA (ACC)

Get alerted when new RECURRENT ADRENOCORTICAL CARCINOMA (ACC) trials appear

New hope for rare cancer: radiation before surgery trial seeks to stop recurrence